Related Experiment Video
Updated: Aug 9, 2026

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
Intracellular signaling of the TGF-beta superfamily by Smad proteins
M Kawabata1, T Imamura, H Inoue
1Department of Biochemistry, Cancer Institute, Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan. mkawabat-ind@umin.u-tokyo.ac.jp
Abstract:
TGF-beta is a potent inhibitor of cell growth, and accumulating evidence suggests that perturbation of the TGF-beta signaling pathway leads to tumorigenesis. Smads are recently identified proteins that mediate intracellular signaling of the TGF-beta superfamily. Smads 2 and 3 are phosphorylated by the TGF-beta type I receptor. Smad4 was originally identified as a candidate tumor suppressor gene in pancreatic cancers. Smads 2 and 3 form complexes with Smad4 upon TGF-beta stimulation. The heteromeric Smad complexes translocate into the nucleus, where they activate expression of target genes. Our recent study demonstrated that Smads exist as monomers in the absence of TGF-beta. Smads 2 and 3 form homo- as well as hetero-oligomers with Smad4 upon ligand stimulation. Both homo-oligomers and hetero-oligomers directly bind to DNA, suggesting that the signaling pathway of Smads may be multiplex. Smads 2 and 3 associate with transcriptional coactivators such as p300 in a ligand-dependent manner, p300 enhances transactivation by TGF-beta, suggesting that coactivators link Smads to the basal transcriptional machinery. A missense mutation of Smad2 identified in colorectal and lung cancers was introduced to Smad3. The mutant, Smad3(DE), blocked the activation of wild-type Smad2 and Smad3. Thus, the missense mutation not only disrupts the function of the wild-type Smad but also creates a dominant-negative Smad, which could actively contribute to oncogenesis.
Insights
Transforming growth factor-beta (TGF-beta) signaling, mediated by Smad proteins, is crucial in preventing cell growth. A specific Smad mutation can disrupt this pathway, potentially driving cancer development.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncology
Background:
- Transforming growth factor-beta (TGF-beta) signaling is a key regulator of cell growth, and its disruption is linked to tumorigenesis.
- Smad proteins (Smads 2, 3, and 4) are critical intracellular mediators of TGF-beta superfamily signaling.
- Smad4 was identified as a tumor suppressor gene in pancreatic cancer.
Purpose of the Study:
- To investigate the oligomerization and DNA-binding properties of Smads upon ligand stimulation.
- To explore the role of coactivators, such as p300, in Smad-mediated gene transactivation.
- To analyze the functional consequences of a specific Smad3 mutation (Smad3(DE)) on Smad signaling and oncogenesis.
Main Methods:
- Investigated Smad oligomerization (homo- and hetero-oligomers) using techniques not specified in the abstract.
- Assessed DNA-binding activity of Smad oligomers.
- Examined ligand-dependent association of Smads with coactivator p300.
- Introduced a cancer-derived Smad2 mutation into Smad3 to create a mutant Smad3(DE).
- Evaluated the effect of Smad3(DE) on the function of wild-type Smad2 and Smad3.
Main Results:
- Smads exist as monomers without TGF-beta stimulation.
- Upon ligand stimulation, Smads 2 and 3 form homo- and hetero-oligomers with Smad4.
- Both homo- and hetero-oligomeric Smads bind directly to DNA, indicating a multiplex signaling pathway.
- Smads 2 and 3 associate with p300 in a ligand-dependent manner, enhancing transactivation.
- The introduced Smad3(DE) mutation blocked the activation of wild-type Smad2 and Smad3.
Conclusions:
- Smad oligomerization and DNA binding upon ligand stimulation suggest a complex, multiplex signaling mechanism.
- Coactivator p300 plays a role in linking Smads to the transcriptional machinery.
- The Smad3(DE) mutation not only impairs Smad function but also acts in a dominant-negative manner, potentially contributing to oncogenesis.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
Hedgehog Signaling Pathway
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...